Lung cancer (non-small cell)
Do you want to receive a message when there is new research on Lung cancer (non-small cell)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence appears above each publication explaining what was studied — and you'll be notified as soon as new research about Lung cancer (non-small cell) is available. View what Premium costs.
Publications and studies (3220)
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot Study. (2023/01/01) ♡
- Analysis of the cluster efficacy and prescription characteristics of traditional Chinese medicine intervention for non-small cell lung cancer based on a clustering algorithm. (2023/01/01) ♡
- Comparison of Plasma Metabolites From Patients With Non-Small Cell Lung Cancer by Erlotinib Treatment and Skin Rash. (2023/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Surgery of Old People-Thoracic Surgery]. (2023/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Predictive Factors Associated with Long-Term Response to Combination Immunotherapy in Patients with Untreated Advanced Non-Small-Cell Lung Cancer: A Multicenter Retrospective Study. (2023/01/01) ♡
- Assessment of Naples prognostic score in predicting survival for small cell lung cancer patients treated with chemoradiotherapy. (2023/01/01) ♡
- Real world prognostic utility of platelet lymphocyte ratio and nutritional status in first-line immunotherapy response in stage IV non-small cell lung cancer. (2023/01/01) ♡
- Exploring the implications of modified advanced lung cancer inflammation index on outcomes in patients with advanced non-small cell lung cancer. (2023/01/01) ♡
- Metastatic potential of T1a and T1b non-small cell lung cancer: analysis in the Czech population. (2023/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Endobronchial localization - arena of two tumors: a case report. (2022/12/31) ♡
- Molecular docking analysis of mefluhybenamine with lung cancer targets (2022/12/31) ♡
- The mechanism of Bai He Gu Jin Tang against non-small cell lung cancer revealed by network pharmacology and molecular docking. (2022/12/30) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Fixed right ventricular collapse: A loculated pericardial effusion due to metastatic pulmonary adenocarcinoma. (2022/12/29) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A case of response to combination treatment with autologous immunotherapy and bevacizumab in advanced non-small cell lung cancer. (2022/12/29) ♡
- Timely Curative Treatment and Overall Mortality Among Veterans With Stage I NSCLC. (2022/12/28) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Effects of Methadone on the Toll-like Receptor 4 Expression in Human Non-Small Cell Lung Carcinoma A549 Cell Line Using In-silico and In Vitro Techniques. (2022/12/26) ♡
- Probing Folate-Responsive and Stage-Sensitive Metabolomics and Transcriptional Co-Expression Network Markers to Predict Prognosis of Non-Small Cell Lung Cancer Patients. (2022/12/20) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Efficacy and safety of Kanglaite plus EGFR-TKI in the treatment of advanced non-small cell lung cancer: A meta-analysis of 13 RCTs. (2022/12/16) ♡
- Gou Qi Zi inhibits proliferation and induces apoptosis through the PI3K/AKT1 signaling pathway in non-small cell lung cancer. (2022/12/14) ♡
- Silibinin Overcomes EMT-driven Lung Cancer Resistance to New-Generation ALK Inhibitors. (2022/12/11) ♡
- Highly sensitive noninvasive early lung cancer detection using DNA methylation topology in sputum-derived epithelial cells. (2022/12/10) ♡
- Association of travel distance, surgical volume, and receipt of adjuvant chemotherapy with survival among patients with resectable lung cancer. (2022/12/08) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. PD-L1 blockade by immune checkpoint inhibitors impairs sensitivity to osimertinib in EGFR mutant non-small cell lung cancer cells. (2022/12/07) ♡
- Shashen-Maidong Decoction inhibited cancer growth under intermittent hypoxia conditions by suppressing oxidative stress and inflammation. (2022/12/05) ♡
- Association of Pretreatment Physical and Geriatric Parameters with Treatment Tolerance and Survival in Elderly Patients with Stage I-II Non-Small Cell Lung Cancer: An Evaluation of Usual Care Data. (2022/12/05) ♡
- Expression of PD-L1 in Lung Carcinoma and Its Correlation with Histopathological Grade, Stage, and Survival of Patients (2022/12/05) ♡
- Dietary factors and the risk of lung cancer by epidermal growth factor receptor mutation status and histological subtypes. (2022/12/02) ♡
- Changes in Body Weight, Body Composition, Phase Angle, and Resting Metabolic Rate in Male Patients with Stage IV Non-Small-Cell Lung Cancer Undergoing Therapy. (2022/12/02) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A case of hepatitis induced by herbal medicine in non-small cell lung cancer patient treated by a combination of immunotherapy and chemotherapy. (2022/12/01) ♡
- IRE1α-XBP1 regulates PDK1-dependent induction of epithelial-mesenchymal transition in non-small cell lung cancer cells. (2022/12/01) ♡
- Explore the mechanism and substance basis of Mahuang FuziXixin Decoction for the treatment of lung cancer based on network pharmacology and molecular docking. (2022/12/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Aqueous Extract of Artemisia annua Shows In Vitro Antimicrobial Activity and an In Vivo Chemopreventive Effect in a Small-Cell Lung Cancer Model. (2022/12/01) ♡
- Cancer cell-derived exosomal miR-425-3p induces white adipocyte atrophy. (2022/12/01) ♡
- Obesity accelerates immune evasion of non-small cell lung carcinoma via TFEB-dependent upregulation of Siglec-15 and glycolytic reprogramming. (2022/12/01) ♡
- Comparative study of TNF-α and vitamin D reveals a significant role of TNF-α in NSCLC in an ethnically conserved vitamin D deficient population. (2022/12/01) ♡
- Gefitinib enhances the anti‑tumor immune response against EGFR‑mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H. (2022/12/01) ♡
- Intraoperative ultrasound: "Alternative eye" in lymph nodal dissection in non-small cell lung cancer. (2022/12/01) ♡
- AZ12756122, a novel fatty acid synthase inhibitor, decreases resistance features in EGFR-TKI resistant EGFR-mutated NSCLC cell models. (2022/12/01) ♡
- Chromium (VI)-induced ALDH1A1/EGF axis promotes lung cancer progression. (2022/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [A Resected Case of Mesenteric Nodal Metastases from Small Cell Lung Carcinoma]. (2022/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A Case of Hypertrophic Pulmonary Osteoarthropathy Associated with Pulmonary Pleomorphic Carcinoma]. (2022/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Is the neutrophil-to-lymphocyte ratio a prognostic factor in non-small cell lung cancer patients who receive adjuvant chemotherapy? (2022/12/01) ♡
- Transcriptome of Lung Cancer Cells Resistant to the Cytotoxic Activity of Macrophages. (2022/12/01) ♡
- Serum circulating free DNA of syncytin-1 as a novel molecular marker for early diagnosis of non-small-cell lung cancer. (2022/12/01) ♡
- Adverse events and clinical outcomes in patients treated with PD-(L)1 blockade for advanced non-small-cell lung cancer. (2022/12/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Combi-TED: a new trial testing Tedopi(®) with docetaxel or nivolumab in metastatic non-small-cell lung cancer progressing after first line. (2022/12/01) ♡
- Low level of complement factor H increases the risk of cancer-related death in patients with small-cell lung cancer. (2022/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report: Dramatic response to alectinib in a lung adenosquamous carcinoma patient harbouring a novel CPE-ALK fusion. (2022/12/01) ♡
- The role and mechanisms of long non-coding RNA LINC00662 in promoting the proliferation, migration, and angiogenesis of BGC-823 and HGC-27 cells and the subsequent effect on the progression of gastric cancer. (2022/12/01) ♡
- Investigation of the effects of mir-219-1 gene variants on the development of disease in non-small cell lung cancer patients. (2022/12/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.